NJ State Employees Deferred Compensation Plan’s Legend Biotech LEGN Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,300	Closed	-$271K	–	222
2025 Q3	$271K	Hold	8,300	–	–	0.03%	372
2025 Q2	$295K	Hold	8,300	–	–	0.03%	348
2025 Q1	$282K	Hold	8,300	–	–	0.04%	363
2024 Q4	$270K	Hold	8,300	–	–	0.03%	386
2024 Q3	$404K	Hold	8,300	–	–	0.05%	338
2024 Q2	$368K	Hold	8,300	–	–	0.05%	340
2024 Q1	$466K	Hold	8,300	–	–	0.06%	304
2023 Q4	$499K	Hold	8,300	–	–	0.07%	286
2023 Q3	$558K	Hold	8,300	–	–	0.08%	247
2023 Q2	$573K	Hold	8,300	–	–	0.08%	249
2023 Q1	$400K	Hold	8,300	–	–	0.06%	325
2022 Q4	$414K	Hold	8,300	–	–	0.07%	303
2022 Q3	$339K	Buy	+8,300	New	+$390K	0.06%	332

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's LEGN Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 8,300 shares — an estimated $271K sold.

NJ State Employees Deferred Compensation Plan first reported a position in LEGN in Q3 2022 and held it in 13 quarters. The position peaked at $573K in Q2 2023. 198 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 8,300 Legend Biotech shares in Q4 2025, an estimated $271K.
NJ State Employees Deferred Compensation Plan first reported a position in Legend Biotech in Q3 2022 and held it in 13 quarters.
NJ State Employees Deferred Compensation Plan's Legend Biotech position peaked at $573K in Q2 2023.
198 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.